EA
ELGX

Emerald Advisers’s Endologix Inc ELGX Stock Holding History

Emerald Advisers’s Portfolio ELGX Stock Details ELGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-2,802
Closed -$125K – 278
2017
Q3 		$125K Sell
2,802
-120
-4% -$5.47K 0.01% 234
2017
Q2 		$142K Sell
2,922
-150
-5% -$8.83K 0.01% 214
2017
Q1 		$222K Buy
+3,072
New +$203K 0.01% 215

Other funds holding ELGX

ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Emerald Advisers's ELGX Position: Q4 2017 in Review

Emerald Advisers sold out of Endologix Inc (ELGX) in Q4 2017, closing a stake of 2,802 shares — an estimated $125K sold.

Emerald Advisers first reported a position in ELGX in Q1 2017 and held it in 3 quarters. The position peaked at $222K in Q1 2017. 103 funds tracked by Wall St. Rank hold ELGX as of Q4 2017.

  • Emerald Advisers reported no remaining Endologix Inc position as of Q4 2017 after selling out during the quarter.
  • Emerald Advisers sold 2,802 Endologix Inc shares in Q4 2017, an estimated $125K.
  • Emerald Advisers first reported a position in Endologix Inc in Q1 2017 and held it in 3 quarters.
  • Emerald Advisers's Endologix Inc position peaked at $222K in Q1 2017.
  • 103 funds tracked by Wall St. Rank held Endologix Inc as of Q4 2017.

Based on Emerald Advisers's 13F filing for Q4 2017, filed 5 Feb 2018.